ANIX: Anixa Biosciences Inc insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
4 open-market buys totaling $181K and 0 sales totaling - in the last 180 days.
Insider buys
| Score | Ticker | Company | Insider | Role | Trade date | Value | Holding + | Cluster |
|---|---|---|---|---|---|---|---|---|
| 46 | ANIX | Anixa Biosciences Inc | Catelani Michael | CFO | 2026-09-30 | $16K | 12% | 4 insiders |
| 46 | ANIX | Anixa Biosciences Inc | Kumar Amit | CEO | 2026-09-24 | $19K | 1% | 4 insiders |
| 36 | ANIX | Anixa Biosciences Inc | Baskies Arnold M | Director | 2026-09-24 | $14K | 4% | 4 insiders |
| 51 | ANIX | Anixa Biosciences Inc | Titterton Lewis H Jr | Director | 2026-09-23 | $132K | 5% | 4 insiders |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.